|
Intelgenx Technologies Corp (IGXT) |
|
Intelgenx Technologies Corp
IGXT's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Intelgenx Technologies growth rates, revenue grew
by 0.58 % in I. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2429
Major Pharmaceutical Preparations industry recorded
growth of revenues by 0.34 %
Intelgenx Technologies net loss increased from $-3 millions, to $-4 millions in I. Quarter 2024,
• More on IGXT's Growth
|
|
Intelgenx Technologies realized a net loss in trailing twelve months.
Intelgenx Technologies realized cash reduction of $ -0 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 26.75.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.44.
• More on IGXT's Valuation
|
|
|
|
|
Intelgenx Technologies realized net loss in trailing twelve months.
Intelgenx Technologies realized cash outflow of $ -0per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 26.75.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.44.
• More on IGXT's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com